Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
about
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapyAzilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.Dietary arginine silicate inositol complex inhibits periodontal tissue loss in rats with ligature-induced periodontitis.Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease.Anti-inflammatory and antiresorptive effects of Calendula officinalis on inflammatory bone loss in rats.
P2860
Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Azilsartan increases levels of ...... erimental periodontitis model.
@en
type
label
Azilsartan increases levels of ...... erimental periodontitis model.
@en
prefLabel
Azilsartan increases levels of ...... erimental periodontitis model.
@en
P2093
P2860
P1433
P1476
Azilsartan increases levels of ...... perimental periodontitis model
@en
P2093
Aurigena Antunes de Araújo
Caroline Addison Carvalho Xavier de Medeiros
Hugo Varela
José Heriberto Oliveira do Nascimento
Lorena de Souza Araújo
Raimundo Fernandes de Araújo Júnior
P2860
P304
P356
10.1371/JOURNAL.PONE.0096750
P407
P50
P577
2014-05-12T00:00:00Z